002166 莱茵生物
已收盘 07-25 15:00:00
资讯
新帖
简况
莱茵生物:公司美国印州工厂升级改造项目近日进入试生产阶段
格隆汇 · 07-02
莱茵生物:公司美国印州工厂升级改造项目近日进入试生产阶段
莱茵生物涨5.94%,华鑫证券一个月前给出“买入”评级
证券之星 · 07-01
莱茵生物涨5.94%,华鑫证券一个月前给出“买入”评级
每周股票复盘:莱茵生物(002166)实施2024年年度权益分派
证券之星 · 06-07
每周股票复盘:莱茵生物(002166)实施2024年年度权益分派
莱茵生物:罗汉果提取物是目前天然甜味剂中的明星产品
证券之星 · 06-04
莱茵生物:罗汉果提取物是目前天然甜味剂中的明星产品
莱茵生物:打造海外高标准植物提取综合生产基地
证券之星 · 06-04
莱茵生物:打造海外高标准植物提取综合生产基地
莱茵生物:公司开发的零界精酿白啤产品属于“零蔗糖”啤酒
证券之星 · 06-04
莱茵生物:公司开发的零界精酿白啤产品属于“零蔗糖”啤酒
莱茵生物:公司持续高度关注行业动态及市场优质投资项目
证券之星 · 05-29
莱茵生物:公司持续高度关注行业动态及市场优质投资项目
莱茵生物:公司已开发零蔗糖啤酒添加天然甜味剂罗汉果提取物
证券之星 · 05-29
莱茵生物:公司已开发零蔗糖啤酒添加天然甜味剂罗汉果提取物
每周股票复盘:莱茵生物(002166)高管计划减持1,018,500股
证券之星 · 05-23
每周股票复盘:莱茵生物(002166)高管计划减持1,018,500股
莱茵生物:公司拥有300多个标准化植物提取产品的技术储备
证券之星 · 05-21
莱茵生物:公司拥有300多个标准化植物提取产品的技术储备
莱茵生物:公司正积极开展麦角硫因的工艺技术开发和验证工作
证券之星 · 05-21
莱茵生物:公司正积极开展麦角硫因的工艺技术开发和验证工作
莱茵生物(002166.SZ)部分董高层拟合计减持不超0.14%股份
智通财经 · 05-21
莱茵生物(002166.SZ)部分董高层拟合计减持不超0.14%股份
莱茵生物最新公告:部分董事、高级管理人员计划减持公司股份
证券之星 · 05-21
莱茵生物最新公告:部分董事、高级管理人员计划减持公司股份
图解莱茵生物一季报:第一季度单季净利润同比增14.95%
证券之星 · 04-25
图解莱茵生物一季报:第一季度单季净利润同比增14.95%
莱茵生物获得外观设计专利授权:“玩偶(星宝)”
证券之星 · 04-24
莱茵生物获得外观设计专利授权:“玩偶(星宝)”
莱茵生物新提交1件商标注册申请
证券之星 · 03-04
莱茵生物新提交1件商标注册申请
莱茵生物(002166.SZ):酶转甜菊糖苷RebM2通过美国FDA GRAS认证
智通财经 · 02-16
莱茵生物(002166.SZ):酶转甜菊糖苷RebM2通过美国FDA GRAS认证
加载更多
公司概况
公司名称:
桂林莱茵生物科技股份有限公司
所属行业:
医药制造业
上市日期:
2007-09-13
主营业务:
桂林莱茵生物科技股份有限公司的主营业务是天然健康产品业务。公司的主要产品是罗汉果提取物、甜叶菊提取物、茶叶提取物、虎杖提取物、积雪草提取物、红景天提取物、槐花提取物、工业大麻提取物。公司以国家级绿色工厂、国家级专精特新“小巨人”企业等权威认证作为背书,依托全产业链布局、技术创新、全球化影响力三大核心优势,确立了自身在全球植物提取领域的领先地位。
发行价格:
9.89
{"stockData":{"symbol":"002166","market":"SZ","secType":"STK","nameCN":"莱茵生物","latestPrice":8.26,"timestamp":1753426983000,"preClose":8.27,"halted":0,"volume":14466301,"delay":0,"changeRate":-0.0012,"floatShares":448000000,"shares":742000000,"eps":0.2252,"marketStatus":"已收盘","change":-0.01,"latestTime":"07-25 15:00:00","open":8.28,"high":8.38,"low":8.23,"amount":120000000,"amplitude":0.0181,"askPrice":8.26,"askSize":655,"bidPrice":8.25,"bidSize":11,"shortable":0,"etf":0,"ttmEps":0.2252,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753666200000},"marketStatusCode":5,"adr":0,"adjPreClose":8.27,"symbolType":"stock","openAndCloseTimeList":[[1753407000000,1753414200000],[1753419600000,1753426800000]],"highLimit":9.1,"lowLimit":7.44,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":741623525,"isCdr":false,"pbRate":1.97,"roa":"--","peRate":36.678508,"roe":"0.99%","epsLYR":0.22,"committee":-0.04965,"marketValue":6126000000,"turnoverRate":0.0323,"status":1,"floatMarketCap":3697000000},"requestUrl":"/m/hq/s/002166","defaultTab":"news","newsList":[{"id":"2548892298","title":"莱茵生物:公司美国印州工厂升级改造项目近日进入试生产阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2548892298","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548892298?lang=zh_cn&edition=full","pubTime":"2025-07-02 20:59","pubTimestamp":1751461195,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0046","BK0028","002166","BK0239","BK0168","BK0174"],"gpt_icon":0},{"id":"2548079608","title":"莱茵生物涨5.94%,华鑫证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2548079608","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548079608?lang=zh_cn&edition=full","pubTime":"2025-07-01 16:27","pubTimestamp":1751358449,"startTime":"0","endTime":"0","summary":"今日莱茵生物涨5.94%,收盘报8.2元。2025年5月6日,华鑫证券研究员孙山山,胡博新,张倩发布了对莱茵生物的研报《公司事件点评报告:营收稳健增长,合成生物持续突破》,该研报对莱茵生物给出“买入”评级。研报中预计2025-2027年EPS分别为0.29/0.38/0.46元,当前股价对应PE分别为25/19/16倍,维持“买入”投资评级。证券之星数据中心计算显示,对该股盈利预测较准的分析师团队为华鑫证券的张倩。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070100026788.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002166","161027"],"gpt_icon":0},{"id":"2541975258","title":"每周股票复盘:莱茵生物(002166)实施2024年年度权益分派","url":"https://stock-news.laohu8.com/highlight/detail?id=2541975258","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541975258?lang=zh_cn&edition=full","pubTime":"2025-06-07 10:29","pubTimestamp":1749263347,"startTime":"0","endTime":"0","summary":"截至2025年6月6日收盘,莱茵生物报收于8.02元,较上周的7.89元上涨1.65%。本周,莱茵生物6月4日盘中最高价报8.41元。莱茵生物当前最新总市值59.48亿元,在化学制品板块市值排名55/169,在两市A股市值排名2516/5148。本周关注点公司公告汇总: 莱茵生物发布2024年年度权益分派实施公告,每10股派发现金红利1.00元(含税)公司公告汇总莱茵生物发布2024年年度权益分派实施公告。本次权益分派股权登记日为2025年6月6日,除权除息日为2025年6月9日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060700010033.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","002166","BK0174","BK0046","BK0168"],"gpt_icon":0},{"id":"2540066974","title":"莱茵生物:罗汉果提取物是目前天然甜味剂中的明星产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2540066974","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540066974?lang=zh_cn&edition=full","pubTime":"2025-06-04 20:56","pubTimestamp":1749041782,"startTime":"0","endTime":"0","summary":"罗汉果提取物是目前天然甜味剂中的明星产品,其甜度倍数高,更具备口感优良、风味遮蔽等特点,属于代糖系列产品中偏高端的产品。近年我们也非常欣喜看到罗汉果提取物市场正在加速拓展,不仅只在奶茶这一细分产业中,越来越多的食品、饮料品牌方都选择加入应用天然甜味剂的队伍中。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060400036441.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","002166","BK0174","BK0168","BK0239","BK0028"],"gpt_icon":0},{"id":"2540066907","title":"莱茵生物:打造海外高标准植物提取综合生产基地","url":"https://stock-news.laohu8.com/highlight/detail?id=2540066907","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540066907?lang=zh_cn&edition=full","pubTime":"2025-06-04 20:56","pubTimestamp":1749041781,"startTime":"0","endTime":"0","summary":"证券之星消息,莱茵生物06月03日在投资者关系平台上答复投资者关心的问题。今年预计该工厂的原料主要以国内生产的半成品以及国外采购原料为主,根据目前规划该工厂投产后,预计将根据客户需求优先排产天然甜味剂等产品。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060400036438.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002166","BK0168","BK0046","BK0028","BK0174"],"gpt_icon":0},{"id":"2540997066","title":"莱茵生物:公司开发的零界精酿白啤产品属于“零蔗糖”啤酒","url":"https://stock-news.laohu8.com/highlight/detail?id=2540997066","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540997066?lang=zh_cn&edition=full","pubTime":"2025-06-04 20:56","pubTimestamp":1749041780,"startTime":"0","endTime":"0","summary":"证券之星消息,莱茵生物(002166)06月03日在投资者关系平台上答复投资者关心的问题。投资者提问:高血糖人士适合喝公司的0蔗糖精酿啤酒吗?莱茵生物回复:您好,公司开发的零界精酿白啤产品属于“零蔗糖”啤酒,通过添加天然甜味剂-罗汉果提取物替代精酿啤酒中原有的糖分,具有低GI产品的属性。尽管如此,基于健康安全考虑,对于有特定健康问题的消费者的饮食建议,还敬请咨询医生等专业人士。感谢您对公司产品的关注和支持,谢谢。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060400036436.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0174","BK0239","002166","BK0028","BK0168","BK0046"],"gpt_icon":0},{"id":"2539263865","title":"莱茵生物:公司持续高度关注行业动态及市场优质投资项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2539263865","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539263865?lang=zh_cn&edition=full","pubTime":"2025-05-29 20:56","pubTimestamp":1748523388,"startTime":"0","endTime":"0","summary":"证券之星消息,莱茵生物(002166)05月28日在投资者关系平台上答复投资者关心的问题。投资者提问:贵司领导您好,近期国家为促进上市公司做大做强,特鼓励并支持上市公司整合资源允许实施并购重组跨界收购,随着社会变迁与经济发展,企业必须向现代化管理方向转型,贵司应抓住历史机遇,请问贵司在并购重组方向上有没有部署?莱茵生物回复:您好,公司持续高度关注行业动态及市场优质投资项目,未来如有相关并购重组计划,公司将严格根据相关法律法规及时履行信息披露义务。谢谢。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052900035477.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","002166","BK0174","BK0239","BK0028","BK0168"],"gpt_icon":0},{"id":"2539887263","title":"莱茵生物:公司已开发零蔗糖啤酒添加天然甜味剂罗汉果提取物","url":"https://stock-news.laohu8.com/highlight/detail?id=2539887263","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539887263?lang=zh_cn&edition=full","pubTime":"2025-05-29 20:56","pubTimestamp":1748523376,"startTime":"0","endTime":"0","summary":"证券之星消息,莱茵生物05月28日在投资者关系平台上答复投资者关心的问题。投资者提问:随着人们健康意识的提高,现在都在流行0蔗糖食品,比如0蔗糖啤酒,请问公司代糖产品能应用在无蔗糖啤酒里吗?","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052900035465.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0174","BK0168","002166","BK0046"],"gpt_icon":0},{"id":"2537163331","title":"每周股票复盘:莱茵生物(002166)高管计划减持1,018,500股","url":"https://stock-news.laohu8.com/highlight/detail?id=2537163331","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537163331?lang=zh_cn&edition=full","pubTime":"2025-05-24 07:51","pubTimestamp":1748044270,"startTime":"0","endTime":"0","summary":"截至2025年5月23日收盘,莱茵生物报收于7.55元,较上周的7.62元下跌0.92%。本周,莱茵生物5月23日盘中最高价报7.81元。莱茵生物当前最新总市值55.99亿元,在化学制品板块市值排名57/169,在两市A股市值排名2590/5148。减持原因为个人资金需求,股份来源为股权激励股份。减持期间如遇送股、资本公积金转增股本等股份变动事项,拟减持股份数量将做相应调整。公司将按规定披露减持计划的实施进展情况,并督促相关人员遵守相关规定,及时履行信息披露义务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052400009860.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002166","BK0239","BK0028","BK0174","BK0168","BK0046"],"gpt_icon":0},{"id":"2537908933","title":"莱茵生物:公司拥有300多个标准化植物提取产品的技术储备","url":"https://stock-news.laohu8.com/highlight/detail?id=2537908933","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537908933?lang=zh_cn&edition=full","pubTime":"2025-05-21 20:52","pubTimestamp":1747831959,"startTime":"0","endTime":"0","summary":"证券之星消息,莱茵生物(002166)05月20日在投资者关系平台上答复投资者关心的问题。投资者提问:公司生产哪些化妆品原料?莱茵生物回复:您好,公司拥有300多个标准化植物提取产品的技术储备,目前生产的植提产品中许多品类都会应用至化妆品领域,如积雪草提取物、葡萄籽提取物、虎杖提取物等,主要功效包括消炎、美白、抗氧化、保湿等,与消费者偏好、品牌方主打概念相匹配。谢谢。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052100037329.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002166","BK0168","BK0046","BK0028","BK0174"],"gpt_icon":0},{"id":"2537946933","title":"莱茵生物:公司正积极开展麦角硫因的工艺技术开发和验证工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2537946933","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537946933?lang=zh_cn&edition=full","pubTime":"2025-05-21 20:52","pubTimestamp":1747831951,"startTime":"0","endTime":"0","summary":"证券之星消息,莱茵生物(002166)05月20日在投资者关系平台上答复投资者关心的问题。投资者提问:公司有麦角硫因相关技术储备吗?莱茵生物回复:您好,据了解,麦角硫因在抗氧化、消炎等方面具备良好的功能特性,公司认为其具有良好的未来市场发展前景。鉴于目前公司合成生物车间产能充足,公司正积极地通过自研以及与相关科研机构合作等多种形式,开展包括麦角硫因在内的多个产品的工艺技术开发和验证工作。谢谢。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052100037326.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002166","BK0168","BK0174","BK0046","BK0028"],"gpt_icon":0},{"id":"2537893361","title":"莱茵生物(002166.SZ)部分董高层拟合计减持不超0.14%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2537893361","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537893361?lang=zh_cn&edition=full","pubTime":"2025-05-21 20:49","pubTimestamp":1747831742,"startTime":"0","endTime":"0","summary":"智通财经APP讯,莱茵生物(002166.SZ)发布公告,公司董事长、总经理谢永富先生,董事、副总经理白昱先生,董事、副总经理兼财务总监郑辉女士,副总经理兼董事会秘书罗华阳先生(以下简称“上述人员”)合计持有公司股份407.4万股,占公司总股本的0.56%(总股本系扣除公司回购专用证券账户上已回购股份后的数量,下同),上述人员计划自公告披露之日起15个交易日后的3个月内以集中竞价方式减持公司股份合计101.85万股(占公司总股本比例0.14%)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1296022.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"莱茵生物(002166.SZ)部分董高层拟合计减持不超0.14%股份","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002166","BK0174","BK0028","BK0239","BK0046","BK0168"],"gpt_icon":0},{"id":"2537382769","title":"莱茵生物最新公告:部分董事、高级管理人员计划减持公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2537382769","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537382769?lang=zh_cn&edition=full","pubTime":"2025-05-21 20:31","pubTimestamp":1747830674,"startTime":"0","endTime":"0","summary":"莱茵生物(002166.SZ)公告称,公司董事长、总经理谢永富,董事、副总经理白昱,董事、副总经理兼财务总监郑辉,副总经理兼董事会秘书罗华阳合计持有公司4,074,000股,占公司总股本的0.56%。上述人员计划自公告披露之日起15个交易日后的3个月内以集中竞价方式减持公司股份合计1,018,500股,占公司总股本比例的0.14%。减持原因为个人资金需求,减持股份来源为所获股权激励股份。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052100036523.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0168","BK0174","BK0239","BK0046","002166","BK0028"],"gpt_icon":0},{"id":"2530788166","title":"图解莱茵生物一季报:第一季度单季净利润同比增14.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530788166","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530788166?lang=zh_cn&edition=full","pubTime":"2025-04-26 02:29","pubTimestamp":1745605786,"startTime":"0","endTime":"0","summary":"证券之星消息,莱茵生物2025年一季报显示,公司主营收入4.44亿元,同比上升30.21%;归母净利润3079.49万元,同比上升14.95%;扣非净利润3613.53万元,同比下降8.68%;负债率36.75%,投资收益-0.04万元,财务费用804.18万元,毛利率22.02%。财报数据概要请见下图:以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042600000970.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002166"],"gpt_icon":0},{"id":"2530960275","title":"莱茵生物获得外观设计专利授权:“玩偶(星宝)”","url":"https://stock-news.laohu8.com/highlight/detail?id=2530960275","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530960275?lang=zh_cn&edition=full","pubTime":"2025-04-25 04:08","pubTimestamp":1745525292,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示莱茵生物新获得一项外观设计专利授权,专利名为“玩偶(星宝)”,专利申请号为CN202430493197.1,授权日为2025年4月25日。今年以来莱茵生物新获得专利授权6个,较去年同期增加了200%。结合公司2024年年报财务数据,2024年公司在研发方面投入了5750.25万元,同比增18.84%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042500004764.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0174","002166","BK0028","BK0239","BK0168","BK0046"],"gpt_icon":0},{"id":"2517984653","title":"莱茵生物新提交1件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2517984653","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517984653?lang=zh_cn&edition=full","pubTime":"2025-03-05 05:44","pubTimestamp":1741124661,"startTime":"0","endTime":"0","summary":"证券之星消息,根据企查查数据显示,近日桂林莱茵生物科技股份有限公司新提交1件商标注册申请。商标申请详情如下:今年以来桂林莱茵生物科技股份有限公司新申请注册商标1件,截止目前公司共持有注册商标398件,另有77件商标尚在注册申请中。数据来源:企查查以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030500004457.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002166","BK0174","BK0168","BK0028","BK0046","BK0239"],"gpt_icon":0},{"id":"2511933082","title":"莱茵生物(002166.SZ):酶转甜菊糖苷RebM2通过美国FDA GRAS认证","url":"https://stock-news.laohu8.com/highlight/detail?id=2511933082","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511933082?lang=zh_cn&edition=full","pubTime":"2025-02-16 16:30","pubTimestamp":1739694608,"startTime":"0","endTime":"0","summary":"智通财经APP讯,莱茵生物 发布公告,近日,公司收到美国食品药品监督管理局的认证通知,公司通过酶转化法生产的瑞鲍迪苷M2正式通过GRAS认证,可作为食品添加剂、膳食补充剂使用。公告称,公司酶转化法生产的RebM2获得美国FDA GRAS认证,标志着该产品的品质和安全性通过了美国食品药品监督管理局的严格审查,具备进入美国食品、饮料市场的准入条件。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1250342.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","BK0239","002166","BK0174","BK0046","BK0168"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1753634880476,"stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0.0755},{"period":"3month","weight":0.0762},{"period":"6month","weight":0.1105},{"period":"1year","weight":0.2538},{"period":"ytd","weight":0.1194}],"compareEarnings":[{"period":"1week","weight":0.0167},{"period":"1month","weight":0.0398},{"period":"3month","weight":0.0906},{"period":"6month","weight":0.1048},{"period":"1year","weight":0.2449},{"period":"ytd","weight":0.0722}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"桂林莱茵生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"52109人(较上一季度增加7.36%)","perCapita":"8589股","listingDate":"2007-09-13","address":"广西壮族自治区桂林市临桂区人民南路19号","registeredCapital":"74162万元","survey":" 桂林莱茵生物科技股份有限公司的主营业务是天然健康产品业务。公司的主要产品是罗汉果提取物、甜叶菊提取物、茶叶提取物、虎杖提取物、积雪草提取物、红景天提取物、槐花提取物、工业大麻提取物。公司以国家级绿色工厂、国家级专精特新“小巨人”企业等权威认证作为背书,依托全产业链布局、技术创新、全球化影响力三大核心优势,确立了自身在全球植物提取领域的领先地位。","listedPrice":9.89},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"莱茵生物(002166)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供莱茵生物(002166)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"莱茵生物,002166,莱茵生物股票,莱茵生物股票老虎,莱茵生物股票老虎国际,莱茵生物行情,莱茵生物股票行情,莱茵生物股价,莱茵生物股市,莱茵生物股票价格,莱茵生物股票交易,莱茵生物股票购买,莱茵生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"莱茵生物(002166)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供莱茵生物(002166)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}